#None #Irvine #Health Technology #blood pressure #Esperto Medical

Esperto Medical™ Secures ARPA-H SBIR Award for Wearable Blood Pressure Monitor

A Major Leap in Hypertension Management

Esperto Medical™ has made headlines by securing a Phase I Small Business Innovation Research (SBIR) award from the Advanced Research Projects Agency for Health (ARPA-H). This prestigious grant is aimed at developing a cutting-edge continuous blood pressure monitoring solution, leveraging the innovative resonance sonomanometry™ (RSM) technology. The project, named 'Continuous, Non-invasive, Calibration-Free Blood Pressure Monitoring by Resonance Sonomanometry,' focuses on creating a wearable, wireless device designed for comprehensive home and ambulatory blood pressure monitoring.

The Challenge of Traditional Measurement Techniques

High blood pressure, commonly known as hypertension, is a widespread health issue affecting over a billion people globally. Despite its prevalence, traditional blood pressure measurement methods have remained relatively unchanged for decades. Current approaches often depend on manual cuff measurements, making diagnosis and management cumbersome and less efficient. Calibration requirements pose frequent challenges, leading to accuracy concerns and limited clinical adoption of wearable devices that could greatly enhance hypertension management.

Revolutionary Resonance Sonomanometry™ Technology

The good news is that Esperto Medical's RSM technology presents an innovative alternative to conventional monitoring systems. Unlike existing methods, which infer blood pressure from other physiological signals, RSM directly measures blood pressure using ultrasound-based resonance sensing. This breakthrough allows for continuous monitoring without the need for periodic calibration, greatly enhancing accuracy and convenience for users. The Phase I project will primarily focus on the technical planning necessary to miniaturize this revolutionary technology into a user-friendly wearable device.

Enhancing Patient Care Through Innovation

As highlighted by Alaina Rajagopal, Co-Founder and Chief Medical Officer of Esperto Medical, this award aligns perfectly with the company's mission to translate RSM technology into a practical wearable remote patient monitoring solution. The direct measurement capabilities of RSM eliminate the complexities of calibration and aim to provide a more reliable and user-friendly experience for patients and healthcare providers alike. Rajagopal affirmed, "Because RSM measures blood pressure directly rather than inferring it from other physiologic signals, we believe it offers significant advantages as a user-friendly and clinically reliable remote monitoring solution."

Commitment to Healthcare Advancement

Founded with the aim of revolutionizing healthcare, Esperto Medical is dedicated to expanding access to innovative and non-invasive diagnostic technologies. The company acknowledges that while medicine is ripe for breakthroughs, traditional practices still impose significant burdens on clinicians. By addressing these challenges and enhancing essential monitoring processes, Esperto Medical is poised to liberate healthcare from outdated technologies and improve patients’ experiences.

Conclusion

In conclusion, the SBIR award from ARPA-H marks a significant step forward for Esperto Medical. With its groundbreaking RSM technology, the company is on the path to potentially transforming hypertension management, offering patients a more efficient and convenient way to monitor their condition. The anticipated wearable device could not only improve the accuracy of blood pressure measurement but also empower individuals to take control of their health in everyday situations. For more information about Esperto Medical and its cutting-edge initiatives, visit www.esperto.health.